Healthcare Industry News: breast brachytherapy
News Release - February 20, 2007
Study Shows MammoPad(R) and Digital Mammography Increase Volume, RevenueALISO VIEJO, Calif.--(HSMN NewsFeed)--A poster at the 2007 conference of the National Consortium of Breast Centers (NCBC) shows how marketing the use of the MammoPad breast cushion with digital mammography can increase a breast center's patient volume and revenue.
JCMHE began using MammoPad in October 2005. The center's annual patient volume increased from 3,610 mammograms per year in 2004 to 7,168 mammograms per year in 2006 -- a 99 percent increase. The center's gross revenue rose as well, increasing 72 percent during the same time period. In 2004, mammography revenue was $1.8 million; it rose to $3.1 million in 2006 following adoption of the breast cushion and the marketing of digital mammography and the breast cushion.
JHMCE's "high-tech, soft-touch" marketing campaign proved to be a successful way of differentiating its services from other healthcare providers in the community. In addition, the increase in patient volume and revenue enables the center to maximize its investment in digital mammography and offset increased costs associated with the transition to digital.
"We faced a tremendous amount of competition in our area, and we knew we had to find a way to differentiate ourselves," said Rob Murphy. "The combination of the new cushion and digital, which was featured in the marketing program, provided a complete package to accomplish both goals: increase patient volume and distinguish our center in the minds of patients and referral sources."
Jewish Hospital Medical Center East is a service of Jewish Hospital and St. Mary's HealthCare, a regional healthcare network that includes 70 healthcare facilities and 1,900 patient beds in Kentucky and southern Indiana. JHMCE is a "next generation" outpatient care facility that has become the standard-bearer for high-tech, patient-focused care. It offers a spa-like atmosphere and the region's most advanced outpatient diagnostic procedures and treatment options in areas such as diagnostic imaging, emergency services, and rehab services.
MammoPad is a radiolucent foam cushion that covers the cold, hard surfaces of all commercially available mammography equipment. Clinical studies show the cushion can reduce discomfort by 50 percent for three out of four women. In November, BioLucent announced that more than 10 million women have experienced a softer, more comfortable mammogram with MammoPad.
BioLucent is a women's health company dedicated to the early detection and treatment of breast cancer. The company's products remove a major barrier to screening mammography and offer an innovative solution to treating early breast cancer. In addition to the MammoPad breast cushion, BioLucent has developed the SAVI(TM) applicator, a new breast brachytherapy device that helps treat breast cancer. For more information, call (toll-free) 866-460-4141 or access www.BioLucent.com
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.